Home/ Supplements/ Carnitine/ L-Carnitine

L-Carnitine

product on market Tablet or Pill Allergy Research Group Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

L-carnitine supports the transport of fatty acids into the mitochondria to be burned for energy. There is moderate research evidence suggesting its role in metabolic function and energy production. This ingredient is generally well-tolerated and maintains a high safety profile.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for L-Carnitine
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
40
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

250 mg
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)

Other Ingredients

Microcrystalline Cellulose Dicalcium Phosphate Silicon Dioxide Magnesium Stearate Stearic Acid Croscarmellose Sodium
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use As a dietary supplement, 1 tablet one or four times daily with meals, or as directed by a healthcare practitioner.

Formulation Notes

Hypoallergenic

Additional Information

L-carnitine is considered a semi-essential amino acid. Free form amino acid, high purity, well tolerated, and in tablet form to insure potency.

Rev. 005

Keep in a cool, dry place, tightly capped.

Metadata

Product Details

UPC / SKU7 13947 70640 8
DSLD Entry Date2015-12-23
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
DSLD ID54205
Data Updated2026-04-11
Research

Research Evidence

80
Research Sources
49
Avg Quality
43
Rct
14
Clinical Trial
11
Systematic Review
9
Meta Analysis
2
Regulatory Source
A Propionyl-L-carnitine for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Carnitine supplements for people with chronic kidney disease requiring dialysis
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Acetyl-L-carnitine for patients with hepatic encephalopathy
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
B Carnitine for fatigue in multiple sclerosis
Systematic Review The Cochrane database of systematic reviews 2012 PubMed DOI
B L-carnitine for cognitive enhancement in people without cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Carnitine for fatigue in multiple sclerosis
Systematic Review The Cochrane database of systematic reviews 2010 PubMed DOI
B Systematic Review and Meta-analysis on Effect of Carnitine, Coenzyme Q10 and Selenium on Pregnancy and Semen Parameters in Couples With Idiopathic Male Infertility
Meta Analysis Urology 2022 PubMed DOI
B Effects of Carnitine and Coenzyme Q10 on Sperm Quality and Pregnancy Rates in Men with Unexplained Infertility: A Systematic Review and Network Meta-Analysis
Systematic Review Reproductive sciences (Thousand Oaks, Calif.) 2025 PubMed DOI
B Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis
Meta Analysis Nutrients 2017 PubMed DOI
View all evidence for Carnitine →
Compare

Similar Products

View all Carnitine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.